| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |